Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yasmin in women with PCOS and healthy controls for breast cell turnover and mammographic density
2009-010288-17Phase 4Active
- Sponsor
- Karolinska University Hospital
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of drospirenone in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Karolinska University Hospital. Primary endpoints: Breast cell turnover, Mammographic density and 2 more. Started Mar 2009; status: active.
02
Drugs
drospirenone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on 2009-010288-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010288-17.